A recent study suggested that TGF-β-mediated NLRP3 inflammasome activation may trigger the release of high-mobility group box 1, thereby exacerbating the pathological progression of Ang II-induced renal fibrosis in hypertensive nephropathy. This evidence concerns the gene NLRP3 and renal fibrosis.